Faculty Collaboration Database

CTSI Cores Search Research Informatics REDCap

Thomas B. Connor MD

Professor

Institution: Medical College of Wisconsin
Department: Ophthalmology and Visual Sciences
Program: Retina

Publications (127)

Human iPSC-derived photoreceptor transplantation in the cone dominant 13-lined ground squirrel. (Yu CT, Kandoi S, Periasamy R, Reddy LVK, Follett HM, Summerfelt P, Martinez C, Guillaume C, Bowie O, Connor TB, Lipinski DM, Allen KP, Merriman DK, Carroll J, Lamba DA) Stem Cell Reports 2024 Mar 12;19(3):331-342 PMID: 38335965 PMCID: PMC10937153 SCOPUS ID: 2-s2.0-85186065745 02/10/2024

Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases. (Mahaling B, Low SWY, Ch S, Addi UR, Ahmad B, Connor TB, Mohan RR, Biswas S, Chaurasia SS) Pharmaceutics 2023 Jul 22;15(7) PMID: 37514191 PMCID: PMC10383092 SCOPUS ID: 2-s2.0-85166338712 07/29/2023 1 Citation

Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. (Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W, AREDS2 Research Group) JAMA Ophthalmol 2022 Jul 01;140(7):692-698 PMID: 35653117 PMCID: PMC9164119 SCOPUS ID: 2-s2.0-85132156980 06/03/2022 44 Citations

Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion. (Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, SCORE2 Investigator Group) Am J Ophthalmol 2022 Aug;240:330-341 PMID: 35461831 PMCID: PMC11064059 SCOPUS ID: 2-s2.0-85131381486 04/25/2022 7 Citations

Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18. (Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, SCORE2 Study Investigator Group) JAMA Ophthalmol 2022 May 01;140(5):458-464 PMID: 35323843 PMCID: PMC8949717 SCOPUS ID: 2-s2.0-85127649163 03/25/2022 3 Citations

Long-term retinal imaging of a case of suspected congenital rubella infection (Langlo CS, Trotter A, Reddi HV, Schilter KF, Tyler RC, Udani R, Neitz M, Carroll J, Connor TB) American Journal of Ophthalmology Case Reports March 2022;25 SCOPUS ID: 2-s2.0-85121217327 03/01/2022 2 Citations

Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders (Mahaling B, Low SWY, Beck M, Kumar D, Ahmed S, Connor TB, Ahmad B, Chaurasia SS) International Journal of Molecular Sciences March-1 2022;23(5) SCOPUS ID: 2-s2.0-85125395177 03/01/2022 15 Citations

SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion. (Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, SCORE2 Investigator Group) Graefes Arch Clin Exp Ophthalmol 2022 May;260(5):1491-1500 PMID: 34842984 PMCID: PMC10887424 SCOPUS ID: 2-s2.0-85120173859 11/30/2021 1 Citation

Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial. (Maguire MG, Liu D, Bressler SB, Friedman SM, Melia M, Stockdale CR, Glassman AR, Sun JK, DRCR Retina Network) JAMA Ophthalmol 2021 Dec 01;139(12):1266-1273 PMID: 34673898 PMCID: PMC8532036 SCOPUS ID: 2-s2.0-85117844742 10/22/2021 14 Citations

Development of a Preclinical Laser Speckle Contrast Imaging Instrument for Assessing Systemic and Retinal Vascular Function in Small Rodents. (Patel DD, Dhalla AH, Viehland C, Connor TB, Lipinski DM) Transl Vis Sci Technol 2021 Aug 02;10(9):19 PMID: 34403474 PMCID: PMC8374978 SCOPUS ID: 2-s2.0-85114392221 08/18/2021 6 Citations

Small leucine-rich proteoglycans (Slrps) in the retina (Low SWY, Connor TB, Kassem IS, Costakos DM, Chaurasia SS) International Journal of Molecular Sciences 2 July 2021;22(14) SCOPUS ID: 2-s2.0-85109111419 07/02/2021 14 Citations

Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial. (Khurana RN, Oden NL, VanVeldhuisen PC, Scott IU, Blodi BA, Ip MS, SCORE2 Investigator Group) Graefes Arch Clin Exp Ophthalmol 2021 Jul;259(7):1839-1851 PMID: 33415354 PMCID: PMC8260624 SCOPUS ID: 2-s2.0-85098955742 01/09/2021 4 Citations

Examining whether aoslo-based foveal cone metrics in achromatopsia and albinism are representative of foveal cone structure (Litts KM, Woertz EN, Wynne N, Brooks BP, Chacon A, Connor TB, Costakos D, Dumitrescu A, Drack AV, Fishman GA, Hauswirth WW, Kay CN, Lam BL, Michaelides M, Pennesi ME, Stepien KE, Strul S, Summers CG, Carroll J) Translational Vision Science and Technology 2021;10(6) SCOPUS ID: 2-s2.0-85106940811 01/01/2021 5 Citations

Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa. (Gopalakrishnan S, Mehrvar S, Maleki S, Schmitt H, Summerfelt P, Dubis AM, Abroe B, Connor TB Jr, Carroll J, Huddleston W, Ranji M, Eells JT) Sci Rep 2020 Nov 23;10(1):20382 PMID: 33230161 PMCID: PMC7684292 SCOPUS ID: 2-s2.0-85096441946 11/25/2020 15 Citations

SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials. (Hendrick A, VanVeldhuisen PC, Scott IU, King J, Blodi BA, Ip MS, Khurana RN, Oden NL, SCORE2 Investigator Group) Am J Ophthalmol 2021 Feb;222:185-193 PMID: 32828880 PMCID: PMC7895852 SCOPUS ID: 2-s2.0-85096393439 08/24/2020 1 Citation

PARACENTRAL ACUTE MIDDLE MACULOPATHY AS A PRESENTING SIGN OF CENTRAL RETINAL ARTERY OCCLUSION IN SICKLE CELL DISEASE TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. (Chua MR, Giovinazzo JV, Kaplan RI, Connor T, Kellner C, Barash A, Rosen RB) Retin Cases Brief Rep 2022 Sep 01;16(5):553-557 PMID: 32618900 SCOPUS ID: 2-s2.0-85136661634 07/04/2020

Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy. (Maguire MG, Liu D, Glassman AR, Jampol LM, Johnson CA, Baker CW, Bressler NM, Gardner TW, Pieramici D, Stockdale CR, Sun JK, DRCR Retina Network) JAMA Ophthalmol 2020 Mar 01;138(3):285-293 PMID: 31999300 PMCID: PMC7042909 SCOPUS ID: 2-s2.0-85078895663 01/31/2020 34 Citations

Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial. (Scott IU, VanVeldhuisen PC, Barton F, Oden NL, Ip MS, Blodi BA, Worrall M, Fish GE, Study of Comparative Treatments for Retinal Vein Occlusion 2 Investigator Group) JAMA Ophthalmol 2019 Aug 01;137(8):932-938 PMID: 31169862 PMCID: PMC6555474 SCOPUS ID: 2-s2.0-85066858664 06/07/2019 7 Citations

Assessing Retinal Structure in Patients with Parkinson's Disease. (Young JB, Godara P, Williams V, Summerfelt P, Connor TB, Tarima S, Visotcky A, Cooper RF, Blindauer K, Carroll J) J Neurol Neurophysiol 2019;10(1) PMID: 31057987 PMCID: PMC6494090 05/07/2019

Successful management of epithelial ingrowth after sequential intracameral 5-fluorouracil and Descemet-stripping automated endothelial keratoplasty. (Koenig SB, Koenig LR, Connor TB, Simons KB) J Cataract Refract Surg 2019 May;45(5):690-693 PMID: 30853320 SCOPUS ID: 2-s2.0-85062388761 03/12/2019 2 Citations

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study. (Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Ghuman T, Baker CW, SCORE2 Investigator Group) JAMA Ophthalmol 2019 Mar 01;137(3):281-287 PMID: 30589922 PMCID: PMC6439712 SCOPUS ID: 2-s2.0-85059231242 12/28/2018 9 Citations

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. (Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY, Age-Related Eye Disease Study 2 Research Group) Ophthalmology 2019 Feb;126(2):261-273 PMID: 30142373 PMCID: PMC6348044 SCOPUS ID: 2-s2.0-85053693825 08/25/2018 37 Citations

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD. (Reid CA, Nettesheim ER, Connor TB, Lipinski DM) Sci Rep 2018 Aug 06;8(1):11763 PMID: 30082848 PMCID: PMC6079038 SCOPUS ID: 2-s2.0-85051247613 08/08/2018 45 Citations

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY, AREDS2 Research Group) Ophthalmology 2018 Dec;125(12):1913-1928 PMID: 30060980 PMCID: PMC6246813 SCOPUS ID: 2-s2.0-85050484301 08/01/2018 127 Citations

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. (Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW, Diabetic Retinopathy Clinical Research Network) JAMA Ophthalmol 2018 Oct 01;136(10):1138-1148 PMID: 30043039 PMCID: PMC6233839 SCOPUS ID: 2-s2.0-85053835460 07/26/2018 267 Citations

Findings in Persistent Retinopathy of Prematurity. (Warren CC, Young JB, Goldberg MR, Connor TB, Kassem IS, Costakos DM) Ophthalmic Surg Lasers Imaging Retina 2018 Jul 01;49(7):497-503 PMID: 30021036 PMCID: PMC6196355 SCOPUS ID: 2-s2.0-85050358307 07/19/2018 9 Citations

Photothermal optical coherence tomography of indocyanine green in ex vivo eyes. (Lapierre-Landry M, Connor TB, Carroll J, Tao YK, Skala MC) Opt Lett 2018 Jun 01;43(11):2470-2473 PMID: 29856406 PMCID: PMC8148624 SCOPUS ID: 2-s2.0-85048005197 06/02/2018 14 Citations

Photophobia in an Immunocompromised Patient. (Desai S, Connor TB Jr, Kopplin LJ) JAMA Ophthalmol 2018 Aug 01;136(8):946-947 PMID: 29799980 SCOPUS ID: 2-s2.0-85051345166 05/26/2018 1 Citation

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. (Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC, Diabetic Retinopathy Clinical Research Network) Ophthalmology 2018 Jul;125(7):1054-1063 PMID: 29525602 PMCID: PMC6568257 SCOPUS ID: 2-s2.0-85042941882 03/12/2018 30 Citations

Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial. (Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM, SCORE2 Investigator Group) JAMA Ophthalmol 2018 Apr 01;136(4):337-345 PMID: 29476687 PMCID: PMC5876862 SCOPUS ID: 2-s2.0-85045540809 02/25/2018 29 Citations

SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion. (Scott IU, Figueroa MJ, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC, SCORE2 Investigator Group) Am J Ophthalmol 2017 Dec;184:147-156 PMID: 29074161 PMCID: PMC5798626 SCOPUS ID: 2-s2.0-85033381238 10/28/2017 8 Citations

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. (Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J, SCORE2 Investigator Group) JAMA 2017 May 23;317(20):2072-2087 PMID: 28492910 PMCID: PMC5710547 SCOPUS ID: 2-s2.0-85019585340 05/12/2017 170 Citations

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4. (Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, King J, Antoszyk AN, Peters MA, Tolentino M, SCORE2 Investigator Group) JAMA Ophthalmol 2017 Jun 01;135(6):639-649 PMID: 28492860 PMCID: PMC5710260 SCOPUS ID: 2-s2.0-85020731716 05/12/2017 38 Citations

SCORE2 Report 2: Study Design and Baseline Characteristics. (Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU, SCORE2 Investigator Group) Ophthalmology 2017 Feb;124(2):245-256 PMID: 27863843 PMCID: PMC5272814 SCOPUS ID: 2-s2.0-85008258125 11/20/2016 24 Citations

Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial. (Jampol LM, Glassman AR, Bressler NM, Wells JA, Ayala AR, Diabetic Retinopathy Clinical Research Network) JAMA Ophthalmol 2016 Dec 01;134(12) PMID: 27711918 PMCID: PMC5567802 SCOPUS ID: 2-s2.0-85011371430 10/07/2016 46 Citations

Cone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency. (Patterson EJ, Wilk M, Langlo CS, Kasilian M, Ring M, Hufnagel RB, Dubis AM, Tee JJ, Kalitzeos A, Gardner JC, Ahmed ZM, Sisk RA, Larsen M, Sjoberg S, Connor TB, Dubra A, Neitz J, Hardcastle AJ, Neitz M, Michaelides M, Carroll J) Invest Ophthalmol Vis Sci 2016 Jul 01;57(8):3853-63 PMID: 27447086 PMCID: PMC4968428 SCOPUS ID: 2-s2.0-84992348116 07/23/2016 30 Citations

Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10. (Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY, Age-Related Eye Disease Study 2 (AREDS2) Research Group) JAMA Ophthalmol 2016 Sep 01;134(9):1041-7 PMID: 27442263 PMCID: PMC8371745 SCOPUS ID: 2-s2.0-84998579492 07/22/2016 21 Citations

Longitudinal evaluation of expression of virally delivered transgenes in gerbil cone photoreceptors (Mauck M, Mancuso K, Kuchenbecker J, Connor TB, Hauswirth W, Neitz j, Neitz M) Visual Neuroscience 25: 273-282 06/24/2016

Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome. (Sun LW, Johnson RD, Langlo CS, Cooper RF, Razeen MM, Russillo MC, Dubra A, Connor TB Jr, Han DP, Pennesi ME, Kay CN, Weinberg DV, Stepien KE, Carroll J) Invest Ophthalmol Vis Sci 2016 May 01;57(6):2428-42 PMID: 27145477 PMCID: PMC5089122 SCOPUS ID: 2-s2.0-84965031047 05/06/2016 83 Citations

Correlating Photoreceptor Mosaic Structure to Clinical Findings in Stargardt Disease. (Razeen MM, Cooper RF, Langlo CS, Goldberg MR, Wilk MA, Han DP, Connor TB Jr, Fishman GA, Collison FT, Sulai YN, Dubra A, Carroll J, Stepien KE) Transl Vis Sci Technol 2016 Mar;5(2):6 PMID: 26981328 PMCID: PMC4790429 SCOPUS ID: 2-s2.0-85005952066 03/17/2016 27 Citations

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. (Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW, Diabetic Retinopathy Clinical Research Network) Ophthalmology 2016 Jun;123(6):1351-9 PMID: 26935357 PMCID: PMC4877252 SCOPUS ID: 2-s2.0-84975698767 03/05/2016 712 Citations

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8. (AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY) Ophthalmology 2016 Apr;123(4):916-7 PMID: 26686966 PMCID: PMC4808327 SCOPUS ID: 2-s2.0-84950146327 12/22/2015 14 Citations

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. (Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network) JAMA Ophthalmol 2016 Feb;134(2):127-34 PMID: 26605836 PMCID: PMC5567793 SCOPUS ID: 2-s2.0-84958526252 11/26/2015 60 Citations

Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. (Brilliant MH, Vaziri K, Connor TB Jr, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW Jr, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS) Am J Med 2016 Mar;129(3):292-8 PMID: 26524704 PMCID: PMC4841631 SCOPUS ID: 2-s2.0-84958047136 11/03/2015 63 Citations

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15. (Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC, SCORE Study Investigator Group) JAMA Ophthalmol 2015 Sep;133(9):1022-9 PMID: 26086920 PMCID: PMC6639714 SCOPUS ID: 2-s2.0-84941313014 06/19/2015 36 Citations

Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. (Aiello LP, Ayala AR, Antoszyk AN, Arnold-Bush B, Baker C, Bressler NM, Elman MJ, Glassman AR, Jampol LM, Melia M, Nielsen J, Wolpert HA, Diabetic Retinopathy Clinical Research Network) JAMA Ophthalmol 2015 Aug;133(8):888-96 PMID: 25996273 PMCID: PMC4924347 SCOPUS ID: 2-s2.0-84939483897 05/23/2015 28 Citations

Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. (Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, Huang SS, Jampol LM, Kim JE, Melia M, Diabetic Retinopathy Clinical Research Network Investigators) JAMA Ophthalmol 2015 May;133(5):589-97 PMID: 25719991 PMCID: PMC4496789 SCOPUS ID: 2-s2.0-84929692038 02/27/2015 66 Citations

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. (Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW) N Engl J Med 2015 Mar 26;372(13):1193-203 PMID: 25692915 PMCID: PMC4422053 SCOPUS ID: 2-s2.0-84925423332 02/19/2015 1248 Citations

Cone structure in subjects with known genetic relative risk for AMD. (Land ME, Cooper RF, Young J, Berg E, Kitchner T, Xiang Q, Szabo A, Ivacic LC, Stepien KE, Page CD, Carroll J, Connor T Jr, Brilliant M) Optom Vis Sci 2014 Aug;91(8):939-49 PMID: 25014365 PMCID: PMC4111779 SCOPUS ID: 2-s2.0-84905121542 07/12/2014 12 Citations

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study. (Boyer DS, Goldbaum M, Leys AM, Starita C, V.I.S.I.O.N. Study Group) Br J Ophthalmol 2014 Nov;98(11):1543-6 PMID: 24997182 SCOPUS ID: 2-s2.0-84911991755 07/06/2014 15 Citations

Relationship between foveal cone specialization and pit morphology in albinism. (Wilk MA, McAllister JT, Cooper RF, Dubis AM, Patitucci TN, Summerfelt P, Anderson JL, Stepien KE, Costakos DM, Connor TB Jr, Wirostko WJ, Chiang PW, Dubra A, Curcio CA, Brilliant MH, Summers CG, Carroll J) Invest Ophthalmol Vis Sci 2014 May 20;55(7):4186-98 PMID: 24845642 PMCID: PMC4098060 SCOPUS ID: 2-s2.0-84904346942 05/23/2014 108 Citations

Outer retinal structure after closed-globe blunt ocular trauma. (Flatter JA, Cooper RF, Dubow MJ, Pinhas A, Singh RS, Kapur R, Shah N, Walsh RD, Hong SH, Weinberg DV, Stepien KE, Wirostko WJ, Robison S, Dubra A, Rosen RB, Connor TB Jr, Carroll J) Retina 2014 Oct;34(10):2133-46 PMID: 24752010 PMCID: PMC4175068 SCOPUS ID: 2-s2.0-84925287064 04/23/2014 30 Citations

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. (Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD) JAMA Ophthalmol 2014 Feb;132(2):142-9 PMID: 24310343 PMCID: PMC4636082 SCOPUS ID: 2-s2.0-84894229056 12/07/2013 329 Citations

Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7. (Domalpally A, Danis RP, Chew EY, Clemons TE, Reed S, Sangiovanni JP, Ferris FL 3rd, Age-Related Eye Disease Study 2 Research Group) Invest Ophthalmol Vis Sci 2013 Sep 05;54(9):5989-94 PMID: 23887802 PMCID: PMC3771555 SCOPUS ID: 2-s2.0-84883647936 07/28/2013 6 Citations

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. (Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG, Diabetic Retinopathy Clinical Research Network) JAMA Ophthalmol 2013 Aug;131(8):1033-40 PMID: 23807371 PMCID: PMC4162127 SCOPUS ID: 2-s2.0-84881646605 06/29/2013 97 Citations

Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). (Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd, AREDS2 Study Group) Invest Ophthalmol Vis Sci 2013 Jul 08;54(7):4548-54 PMID: 23620429 PMCID: PMC3706107 SCOPUS ID: 2-s2.0-84879970945 04/27/2013 92 Citations

Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. (Diabetic Retinopathy Clinical Research Network*) JAMA Ophthalmol 2013 Mar;131(3):283-93 PMID: 23370902 PMCID: PMC4217122 SCOPUS ID: 2-s2.0-84875172451 02/02/2013 86 Citations

Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. (Busbee BG, Ho AC, Brown DM, Heier JS, Suñer IJ, Li Z, Rubio RG, Lai P, HARBOR Study Group) Ophthalmology 2013 May;120(5):1046-56 PMID: 23352196 SCOPUS ID: 2-s2.0-84877759606 01/29/2013 422 Citations

The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic. (Carroll J, Dubra A, Gardner JC, Mizrahi-Meissonnier L, Cooper RF, Dubis AM, Nordgren R, Genead M, Connor TB Jr, Stepien KE, Sharon D, Hunt DM, Banin E, Hardcastle AJ, Moore AT, Williams DR, Fishman G, Neitz J, Neitz M, Michaelides M) Invest Ophthalmol Vis Sci 2012 Dec 05;53(13):8006-15 PMID: 23139274 PMCID: PMC3816954 SCOPUS ID: 2-s2.0-84873337052 11/10/2012 73 Citations

Imaging the photoreceptor mosaic with adaptive optics: beyond counting cones. (Godara P, Wagner-Schuman M, Rha J, Connor TB Jr, Stepien KE, Carroll J) Adv Exp Med Biol 2012;723:451-8 PMID: 22183364 PMCID: PMC3325514 SCOPUS ID: 2-s2.0-84855969041 12/21/2011 17 Citations

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham. (Loftus JV, Sultan MB, Pleil AM, Macugen 1013 Study Group) Invest Ophthalmol Vis Sci 2011 Sep 29;52(10):7498-505 PMID: 21896838 SCOPUS ID: 2-s2.0-84856386357 09/08/2011 30 Citations

Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. (Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD, Diabetic Retinopathy Clinical Research Network) Invest Ophthalmol Vis Sci 2011 Aug 03;52(9):6168-73 PMID: 21571677 PMCID: PMC3176025 SCOPUS ID: 2-s2.0-80051532218 05/17/2011 33 Citations

A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. (Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS, Macugen 1013 Study Group) Ophthalmology 2011 Jun;118(6):1107-18 PMID: 21529957 SCOPUS ID: 2-s2.0-79958012399 05/03/2011 144 Citations

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. (Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G, Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group) Ophthalmology 2011 Feb;118(2):345-52 PMID: 20926135 PMCID: PMC3020981 SCOPUS ID: 2-s2.0-79551548893 10/12/2010 73 Citations

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. (Friberg TR, Tolentino M, LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M) Br J Ophthalmol 2010 Dec;94(12):1611-7 PMID: 20472746 PMCID: PMC2991041 SCOPUS ID: 2-s2.0-78649858371 05/18/2010 45 Citations

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. (Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK) Ophthalmology 2010 Jun;117(6):1064-1077.e35 PMID: 20427088 PMCID: PMC2937272 SCOPUS ID: 2-s2.0-77952779304 04/30/2010 1230 Citations

RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease. (Koozekanani DD, Connor TB Jr, Wirostko WJ) Ophthalmic Surg Lasers Imaging 2010 Mar 09:1-3 PMID: 20337287 03/27/2010

Physician assessment of changing lesion size of predominantly classic choroidal neovascular membranes in age-related macular degeneration. (Covert DJ, Han DP, Kim JE, Connor TB Jr, Wirostko WJ, Moon SJ, Hamilton R) Ophthalmic Surg Lasers Imaging 2009;40(6):554-60 PMID: 19928720 SCOPUS ID: 2-s2.0-72249116170 11/26/2009

Gene therapy for red-green colour blindness in adult primates. (Mancuso K, Hauswirth WW, Li Q, Connor TB, Kuchenbecker JA, Mauck MC, Neitz J, Neitz M) Nature 2009 Oct 08;461(7265):784-7 PMID: 19759534 PMCID: PMC2782927 SCOPUS ID: 2-s2.0-70349971731 09/18/2009 255 Citations

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. (Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH, SCORE Study Research Group) Arch Ophthalmol 2009 Sep;127(9):1101-14 PMID: 19752419 PMCID: PMC2872173 SCOPUS ID: 2-s2.0-70349243148 09/16/2009 444 Citations

Transconjunctival 20-gauge pars plana vitrectomy using a single entry cannulated sutureless system. (Kim JE, Shah SN, Choi DL, Han DP, Connor TB) Retina 2009 Oct;29(9):1294-8 PMID: 19696700 SCOPUS ID: 2-s2.0-70350138262 08/22/2009 13 Citations

SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. (Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN, SCORE Study Investigator Group) Am J Ophthalmol 2009 Nov;148(5):725-732.e7 PMID: 19674727 PMCID: PMC2780008 SCOPUS ID: 2-s2.0-70350571655 08/14/2009 42 Citations

Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. (George B, Wirostko WJ, Connor TB, Choong NW) J Thorac Oncol 2009 May;4(5):661-2 PMID: 19395911 SCOPUS ID: 2-s2.0-67651159238 04/28/2009 35 Citations

Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. (Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM, Pegaptanib in Central Retinal Vein Occlusion Study Group) Arch Ophthalmol 2009 Apr;127(4):374-80 PMID: 19365011 SCOPUS ID: 2-s2.0-65249132359 04/15/2009 84 Citations

Microbiological spectrum of organisms isolated from explanted scleral buckles. (Wirostko WJ, Covert DJ, Han DP, Connor TB Jr, Kim JE, Hammersley J, Lindgren K) Ophthalmic Surg Lasers Imaging 2009;40(2):201-2 PMID: 19320315 SCOPUS ID: 2-s2.0-64849115805 03/27/2009 18 Citations

SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. (Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M, SCORE Study Investigator Group) Ophthalmology 2009 Mar;116(3):504-12 PMID: 19167078 PMCID: PMC2851408 SCOPUS ID: 2-s2.0-61349153538 01/27/2009 105 Citations

Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. (Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J, Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group) Arch Ophthalmol 2009 Jan;127(1):13-21 PMID: 19139332 SCOPUS ID: 2-s2.0-58449085584 01/14/2009 86 Citations

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. (Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group) Ophthalmology 2009 Jan;116(1):57-65.e5 PMID: 19118696 SCOPUS ID: 2-s2.0-57949094834 01/03/2009 1187 Citations

Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. (Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H, Diabetic Retinopathy Clinical Research Network) Ophthalmology 2008 Aug;115(8):1366-71, 1371.e1 PMID: 18675696 PMCID: PMC2748270 SCOPUS ID: 2-s2.0-48149104805 08/05/2008 139 Citations

Risk factors for scleral buckle removal: a matched, case-control study. (Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Kim JE) Am J Ophthalmol 2008 Sep;146(3):434-439 PMID: 18614132 SCOPUS ID: 2-s2.0-49749125215 07/11/2008 18 Citations

Longitudinal evaluation of expression of virally delivered transgenes in gerbil cone photoreceptors. (Mauck MC, Mancuso K, Kuchenbecker JA, Connor TB, Hauswirth WW, Neitz J, Neitz M) Vis Neurosci 2008;25(3):273-82 PMID: 18598398 PMCID: PMC2643299 SCOPUS ID: 2-s2.0-46749138311 07/05/2008 7 Citations

Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes. (Bhavsar AR, Grillone LR, McNamara TR, Gow JA, Hochberg AM, Pearson RK, Vitrase for Vitreous Hemorrhage Study Groups) Invest Ophthalmol Vis Sci 2008 Oct;49(10):4219-25 PMID: 18441312 SCOPUS ID: 2-s2.0-53449091428 04/29/2008 9 Citations

Risk factors for scleral buckle removal: a matched, case-control study. (Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Kim JE) Trans Am Ophthalmol Soc 2008;106:171-7; discussion 177-8 PMID: 19277232 PMCID: PMC2646451 SCOPUS ID: 2-s2.0-63049096912 01/01/2008 2 Citations

Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. (Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR, MARINA Study Group) Arch Ophthalmol 2007 Nov;125(11):1460-9 PMID: 17998507 SCOPUS ID: 2-s2.0-36148980784 11/14/2007 203 Citations

Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. (Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group) Ophthalmology 2007 Oct;114(10):1868-75 PMID: 17628683 SCOPUS ID: 2-s2.0-34748844162 07/14/2007 194 Citations

Recombinant adeno-associated virus targets passenger gene expression to cones in primate retina. (Mancuso K, Hendrickson AE, Connor TB Jr, Mauck MC, Kinsella JJ, Hauswirth WW, Neitz J, Neitz M) J Opt Soc Am A Opt Image Sci Vis 2007 May;24(5):1411-6 PMID: 17429487 SCOPUS ID: 2-s2.0-34249721535 04/13/2007 27 Citations

Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. (Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR, MARINA Study Group) Ophthalmology 2007 Feb;114(2):246-52 PMID: 17270674 SCOPUS ID: 2-s2.0-33846586501 02/03/2007 365 Citations

Ranibizumab versus verteporfin for neovascular age-related macular degeneration. (Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group) N Engl J Med 2006 Oct 05;355(14):1432-44 PMID: 17021319 SCOPUS ID: 2-s2.0-33749451356 10/06/2006 3164 Citations

Transpupillary thermotherapy with indocyanine green dye enhancement for the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. (Kim JE, Shah KB, Han DP, Connor TB Jr) Ophthalmic Surg Lasers Imaging 2006;37(4):272-7 PMID: 16898386 SCOPUS ID: 2-s2.0-33746679288 08/11/2006 7 Citations

Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. (Mruthyunjaya P, Wirostko WJ, Chandrashekhar R, Stinnett S, Lai JC, Deramo V, Tang J, Dev S, Postel EA, Connor TB, Fekrat S) Retina 2006 Mar;26(3):285-91 PMID: 16508428 SCOPUS ID: 2-s2.0-33646461756 03/02/2006 25 Citations

The role of intravitreal dexamethasone as an adjunct in the management of postoperative bacterial endophthalmitis (Dev S, Han DP, Mieler WF, Gonzalez-Vivas R, Pulido JS, Mittra RA, Connor TB) EVRS Educational Electronic Journal 2005;1(5):10-17 SCOPUS ID: 2-s2.0-33746343383 12/01/2005 3 Citations

Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. (Kuppermann BD, Thomas EL, de Smet MD, Grillone LR, Vitrase for Vitreous Hemorrhage Study Groups) Am J Ophthalmol 2005 Oct;140(4):585-97 PMID: 16226510 SCOPUS ID: 2-s2.0-26844577329 10/18/2005 75 Citations

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. (Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD, Macugen Diabetic Retinopathy Study Group) Ophthalmology 2005 Oct;112(10):1747-57 PMID: 16154196 SCOPUS ID: 2-s2.0-25844513658 09/13/2005 552 Citations

Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. (Kuppermann BD, Thomas EL, de Smet MD, Grillone LR, Vitrase for Vitreous Hemorrhage Study Groups) Am J Ophthalmol 2005 Oct;140(4):573-84 PMID: 16125661 SCOPUS ID: 2-s2.0-26844520874 08/30/2005 89 Citations

Pegaptanib for neovascular age-related macular degeneration. (Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group) N Engl J Med 2004 Dec 30;351(27):2805-16 PMID: 15625332 SCOPUS ID: 2-s2.0-11144239923 12/31/2004 2199 Citations

Transpupillary thermotherapy of occult choroidal neovascularization in age-related macular degeneration. (Kim JE, Perkins SL, Schwiesow T, Connor TB Jr, Han DP) Semin Ophthalmol 2001 Jun;16(2):86-9 PMID: 15491009 SCOPUS ID: 2-s2.0-0035735036 10/20/2004 17 Citations

Subconjunctival antibiotics for acute postcataract extraction endophthalmitis--is it necessary? (Iyer MN, Han DP, Yun HJ, Eastwood D, Kim JE, Connor TB, Wirostko WJ, Dev S) Am J Ophthalmol 2004 Jun;137(6):1120-1 PMID: 15183800 SCOPUS ID: 2-s2.0-2942622117 06/09/2004 21 Citations

Endogenous ocular nocardiosis. (Kim JE, Landon RE, Connor TB Jr, Kivlin JD) J AAPOS 2004 Apr;8(2):194-5 PMID: 15088059 SCOPUS ID: 2-s2.0-1842786948 04/17/2004 6 Citations

Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. (Levin DS, Han DP, Dev S, Wirostko WJ, Mieler WF, Connor TB, George V, Eastwood D) Am J Ophthalmol 2002 Feb;133(2):196-202 PMID: 11812422 SCOPUS ID: 2-s2.0-0036141498 01/29/2002 46 Citations

Hypotony and retinal complications after aqueous humor shunt implantation: the 1999 Dohlman Lecture. (Wirostko WJ, Mieler WF, Levin DS, Law SK, Kalenak JW, Trible JR, Connor TB Jr, Pulido JS, Han DP) Int Ophthalmol Clin 2000;40(1):1-12 PMID: 10713910 SCOPUS ID: 2-s2.0-0033970015 03/14/2000 5 Citations

The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation after pars plana vitrectomy with long-acting gas tamponade. (Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Pulido JS, Connor TB) Ophthalmology 2000 Mar;107(3):588-92 PMID: 10711900 SCOPUS ID: 2-s2.0-0034080833 03/11/2000 28 Citations

Recurrent poststreptococcal uveitis. (Wirostko WJ, Connor TB Jr, Wagner PF) Arch Ophthalmol 1999 Dec;117(12):1649-50 PMID: 10604675 SCOPUS ID: 2-s2.0-0033405609 12/22/1999 11 Citations

A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group. (Banker AS, Freeman WR, Azen SP, Lai MY) Arch Ophthalmol 1999 Nov;117(11):1499-502 PMID: 10565518 SCOPUS ID: 2-s2.0-0032741986 11/24/1999 56 Citations

A 14-year old boy with presumed autosomal dominant macular dystrophy causing moderate visual impairment with no discernible progression over several years. (Ruttum M, Connor TB Jr, Traboulsi EI) J Pediatr Ophthalmol Strabismus 1999;36(5):287-91 PMID: 10505834 SCOPUS ID: 2-s2.0-0033194482 10/03/1999

The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade. (Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Connor TB) Trans Am Ophthalmol Soc 1998;96:143-51; discussion 151-4 PMID: 10360287 PMCID: PMC1298393 SCOPUS ID: 2-s2.0-0032425101 06/09/1999 3 Citations

Progression of diabetic retinopathy after endophthalmitis. (Dev S, Pulido JS, Tessler HH, Mittra RA, Han DP, Mieler WF, Connor TB Jr) Ophthalmology 1999 Apr;106(4):774-81 PMID: 10201602 SCOPUS ID: 2-s2.0-0033505621 04/14/1999 29 Citations

Echographic characteristics of retinal arterial macroaneurysm. (Tang WM, Pulido JS, Connor TB Jr, Sternberg P Jr, Lewandowski MF) Retina 1998;18(6):559-63 PMID: 9869469 SCOPUS ID: 2-s2.0-0032471462 12/30/1998 1 Citation

Suprachoroidal hemorrhage: outcome of surgical management according to hemorrhage severity. (Wirostko WJ, Han DP, Mieler WF, Pulido JS, Connor TB Jr, Kuhn E) Ophthalmology 1998 Dec;105(12):2271-5 PMID: 9855159 SCOPUS ID: 2-s2.0-0032471770 12/17/1998 62 Citations

Comparison of pneumatic retinopexy and scleral buckling in the management of primary rhegmatogenous retinal detachment. Southern Wisconsin Pneumatic Retinopexy Study Group. (Han DP, Mohsin NC, Guse CE, Hartz A, Tarkanian CN) Am J Ophthalmol 1998 Nov;126(5):658-68 PMID: 9822229 SCOPUS ID: 2-s2.0-0032212813 11/20/1998 102 Citations

Visual outcomes following lensectomy and vitrectomy for combined anterior and posterior persistent hyperplastic primary vitreous. (Mittra RA, Huynh LT, Ruttum MS, Mieler WF, Connor TB, Han DP, Pulido JS, Dev S) Arch Ophthalmol 1998 Sep;116(9):1190-4 PMID: 9747677 SCOPUS ID: 2-s2.0-0032449443 09/25/1998 60 Citations

Removal of dislocated intraocular lenses using pars plana vitrectomy with placement of an open-loop, flexible anterior chamber lens. (Mittra RA, Connor TB, Han DP, Koenig SB, Mieler WF, Pulido JS) Ophthalmology 1998 Jun;105(6):1011-4 PMID: 9627650 SCOPUS ID: 2-s2.0-0031862769 06/17/1998 44 Citations

Management of dislocated posterior chamber intraocular lenses using pars plana vitrectomy combined with insertion of an anterior chamber lens (Mittra RA, Connor TB, Han OP, Mieler WF, Pulido JS) Investigative Ophthalmology and Visual Science 1997;38(4) SCOPUS ID: 2-s2.0-33749219487 12/01/1997

Suprachoroidal hemorrhage: A classification of severity and its association with visual and anatomic outcome (Wirostko WJ, Han OP, Mieler WF, Pulido JS, Connor TB, Hartz AJ, Guse CE) Investigative Ophthalmology and Visual Science 1997;38(4) SCOPUS ID: 2-s2.0-33749232806 12/01/1997

Retinal complications after aqueous shunt surgical procedures for glaucoma. (Law SK, Kalenak JW, Connor TB Jr, Pulido JS, Han DP, Mieler WF) Arch Ophthalmol 1996 Dec;114(12):1473-80 PMID: 8953978 SCOPUS ID: 2-s2.0-0029951316 12/01/1996 81 Citations

The adjustable globe: a technique for adjustable strabismus surgery. (Connor TB, Guyton DL, Repka MX, Jain R) J Pediatr Ophthalmol Strabismus 1996;33(3):156-63 PMID: 8771517 SCOPUS ID: 2-s2.0-0030028234 05/01/1996

Retinal complications following glaucoma aqueous-shunt surgery (Law SK, Kalenak JK, Connor TB, Pulido JS, Han DP, Mieler WF) Investigative Ophthalmology and Visual Science 15 February 1996;37(3) SCOPUS ID: 2-s2.0-33750150054 02/15/1996

Bilateral macular vitelliform lesions in a thrombocytopenic patient. (Raja SC, Fekrat S, Connor TB Jr) Arch Ophthalmol 1995 Apr;113(4):411-3 PMID: 7710386 SCOPUS ID: 2-s2.0-0028946781 04/01/1995 4 Citations

Surgical removal of an extrafoveal fibrotic choroidal neovascular membrane with foveal serous detachment in age-related macular degeneration. (Connor TB Jr, Wolf MD, Arrindell EL, Mieler WF) Retina 1994;14(2):125-9 PMID: 7518605 SCOPUS ID: 2-s2.0-0028234326 01/01/1994 61 Citations

Management of aphakic and pseudophakic cystoid macular edema (Connor TB, Pulido JS) Current Opinion in Ophthalmology 1993;4(3):90-101 SCOPUS ID: 2-s2.0-0027151859 01/01/1993 8 Citations

Chemosis as a presenting sign of systemic lupus erythematosus. (Leahey AB, Connor TB, Gottsch JD) Arch Ophthalmol 1992 May;110(5):609-10 PMID: 1580831 SCOPUS ID: 2-s2.0-0026750824 05/01/1992 7 Citations

Ocular penetration of thiabendazole. (Maguire AM, Zarbin MA, Connor TB, Justin J) Arch Ophthalmol 1990 Dec;108(12):1675 PMID: 2256834 SCOPUS ID: 2-s2.0-0025676308 12/01/1990 13 Citations

Systemic amiloride inhibits experimentally induced neovascularization. (Avery RL, Connor TB Jr, Farazdaghi M) Arch Ophthalmol 1990 Oct;108(10):1474-6 PMID: 1699514 SCOPUS ID: 2-s2.0-0025130655 10/11/1990 51 Citations

Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. (Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M) J Clin Invest 1989 May;83(5):1661-6 PMID: 2708527 PMCID: PMC303874 SCOPUS ID: 2-s2.0-0024559791 05/01/1989 463 Citations

Transforming growth factor beta. A biologic chorioretinal glue. (Smiddy WE, Glaser BM, Green WR, Connor TB Jr, Roberts AB, Lucas R, Sporn MB) Arch Ophthalmol 1989 Apr;107(4):577-80 PMID: 2705928 SCOPUS ID: 2-s2.0-0024506872 04/01/1989 79 Citations

Hyperpigmentation following the use of bleaching creams. Localized exogenous ochronosis. (Connor T, Braunstein B) Arch Dermatol 1987 Jan;123(1):105-6, 108 PMID: 3800410 SCOPUS ID: 2-s2.0-84943674697 01/01/1987 17 Citations

Degradation of basement membrane components by vascular endothelial cells: role in neovascularization. (Glaser BM, Kalebic T, Garbisa S, Connor TB Jr, Liotta LA) Ciba Found Symp 1983;100:150-62 PMID: 6197258 SCOPUS ID: 2-s2.0-0021004321 01/01/1983 16 Citations

Protamine inhibits plasminogen activator derived from vascular endothelial cells and tumor cells (Glaser BM, Connor TB) Journal of Cell Biology 1982;95(2 II) SCOPUS ID: 2-s2.0-0020462824 01/01/1982

Last update: 03/30/2024

© 2024 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty

Thomas B. Connor MD

Professor

Publications (127)